We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




The Great Potential of Quantum Dot Imaging

By Biotechdaily staff writers
Posted on 10 Feb 2005
The development of nanocrystals known as quantum dots over the past 20 years has evolved into a new method that allows scientists to study cell processes at the level of an individual molecule, and may result in better ways to detect and treat cancers.

Semiconductor fluorescent quantum dots, called qdots, also have potential for high-resolution cellular imaging and the long-term study of single molecules and their movement within cells, according to researchers at the University of California, Los Angeles (UCLA; CA, USA) and Stanford University (Palo Alto, CA, USA). More...
The investigators published their work in the January 28, 2005, issue of the journal Science.

Qdot imaging is a new way to see biologic processes functioning within cells and in small animals. Probes can be attached to a specific protein or receptor to track it and see what other molecules it interacts with, what areas of the cell it is in, and what signaling pathways the protein may use for performing typical cell functions and abnormal functions that may result in cancer. Because qdots are nanocrystals--minuscule bits of rock one-billionth of a meter in size--they provide excellent contrast for imaging with an electron microscope.

The UCLA investigators believe that qdots might be utilized one day to do two things--diagnose and treat cancer. The technology will enable investigators to find a tumor within the body, look at it very specifically at the cellular level to determine what kind of cancer it is, and then maybe arm it with therapies developed to kill the disease.

Qdots have so much potential because they can be color-coded, with different colors utilized to label different cell mechanisms, different cancers, or different stages of the same cancer. At present, a positron emission tomography (PET) scan can tell clinicians the sites of tumors throughout the body, based on targeting the PET probe to an individual tumor marker. However, with qdots, several different markers of the same tumor could be simultaneously "painted,” producing a color barcode for real-time optical biopsy and diagnosis.

In the study, qdots were labeled with a positron-emitting isotope and injected into mice. Utilizing a PET scanner, scientists were able to watch over time as the qdots traveled through the vascular system and to the liver. The same technique may be used with patients, who could be injected with a mixture of different colored qdots that would label the cancer cells. Once they accumulate at the tumor site, the positrons emitted from the qdots could be imaged with PET scanners.






Related Links:
University of California, Los Angeles

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Urine Analyzer
respons® UDS100
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Longitudinal Heart Stress Assessment Improves Prediction of Cardiovascular Outcomes

Accurately predicting cardiovascular disease (CVD) risk in older adults is challenging when assessments rely on single, point-in-time biomarker measurements. Dynamic indicators that reflect evolving cardiac... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.